Frequent Loss-of-Heterozygosity in CRISPR-Cas9-edited Early Human Embryos Endangered Species He currently is holding a

He currently is holding a position as clinical investigation manager at Vitrolife

Clinical Epigenetics 11(1): 21

This presentation is sponsored by CooperSurgical Fertility and Genomic Solutions

across the CARE Fertility Group in the UK and Ireland

She remains fascinated by this complex problem

Frequent Loss-of-Heterozygosity in CRISPR-Cas9-edited Early Human Embryos Endangered Species He currently is holding aFrequent Loss of Heterozygosity in CRISPR Cas9 edited Early Human Embryos DR. GREGORIO ALANIS LOBATO Gregorio obtained a BEng degree in Computer Systems Engineering at the National Polytechnic Institute in Mexico before moving to KAUST in Saudia Arabia to pursue MSc and PhD degrees in Computer Science and Computational Biology, respectively. Then, he became a postdoctoral fellow at the IMB in Mainz, Germany, where he developed methods to study the